JUN 17, 2019 7:59 AM PDT

Promising Hypertension Drug for Alzheimer Disease

WRITTEN BY: Nouran Amin

In a study led by the American Heart Association, the blood pressure drug nilvadipine (a calcium channel blocker) was found to increase blood flow to the brains memory and learning center in individuals with Alzheimer's disease without adverse effects to other regions of the brain. The study was published in the journal Hypertension and indicates that a decrease in cerebral blood flow in patients with Alzheimer's can be reversed in some regions.

Alzheimer disease is a form of dementia with a risk that increases with age. Causes for Alzheimer disease still remain unknown but earlier studies have shown that blood flow to the brain declines in the early stages of Alzheimer disease. Other studies implied that possible high blood pressure treatment may reduce the risk of dementia possibly because of the beneficial effects on brain blood flow.

"This high blood pressure treatment holds promise as it doesn't appear to decrease blood flow to the brain, which could cause more harm than benefit," said study lead author Jurgen Claassen, M.D., Ph.D., associate professor at Radboud University Medical Center in Nijmegen, the Netherlands. "Even though no medical treatment is without risk, getting treatment for high blood pressure could be important to maintain brain health in patients with Alzheimer's disease."

Learn more about Alzheimer Disease:

 

 

"In the future, we need to find out whether the improvement in blood flow, especially in the hippocampus, can be used as a supportive treatment to slow down progression of Alzheimer's disease, especially in earlier stages of disease," Claassen said.

The study was the first to utilize MRI technique to observe the effects of treatment on cerebral blood flow.

Source: American Heart Association

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
Acid-Reflux Drugs May Negatively Impact Breast Cancer Survivors
Many of us have taken some form of an acid-reflux drug—especially after a meal that causes discomfort. However, now researchers are indicating that s...
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
Treating Malaria: Molecular Understanding of Drug Interactions
Crystallization is a process central to drug development that despite centuries of facilitating a particular method, chemists are still learning how to gra...
JAN 18, 2020
Drug Discovery & Development
JAN 18, 2020
Drug Combo Targets Osteoarthritis
Individuals suffering from osteoarthritis often face challenges of limited treatment options mainly pain relievers or joint replacement surgery. However, s...
FEB 11, 2020
Cannabis Sciences
FEB 11, 2020
Traffic Light System Best Way to Label Cannabis Edibles
Cannabis products have become increasingly popular. Yet, as they are still relatively new to the market, research has found that most consumers don’t...
MAR 18, 2020
Genetics & Genomics
MAR 18, 2020
Finding a Treatment for Fetal Alcohol Spectrum Disorder
When developing fetuses are exposed to any amount of alcohol, they are at risk for a variety of irreversible birth defects....
MAR 16, 2020
Drug Discovery & Development
MAR 16, 2020
Understanding How an Obesity-Treating Drug Functions
Liraglutide is a drug targeted to help treat obesity by suppressing appetite, thus making the patient lose weight. However, up until now research has not d...
Loading Comments...